Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $6.82 billion. The enterprise value is $5.28 billion.
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 81.64 million shares outstanding. The number of shares has increased by 12.59% in one year.
| Current Share Class | 81.64M |
| Shares Outstanding | 81.64M |
| Shares Change (YoY) | +12.59% |
| Shares Change (QoQ) | +2.99% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 78.60% |
| Float | 54.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 173.84 |
| Forward PS | 182.89 |
| PB Ratio | 4.30 |
| P/TBV Ratio | 4.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 134.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.05.
| Current Ratio | 10.47 |
| Quick Ratio | 10.19 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -933.90 |
Financial Efficiency
Return on equity (ROE) is -25.78% and return on invested capital (ROIC) is -16.71%.
| Return on Equity (ROE) | -25.78% |
| Return on Assets (ROA) | -15.87% |
| Return on Invested Capital (ROIC) | -16.71% |
| Return on Capital Employed (ROCE) | -20.82% |
| Weighted Average Cost of Capital (WACC) | 16.68% |
| Revenue Per Employee | $164,752 |
| Profits Per Employee | -$1.31M |
| Employee Count | 238 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +163.38% in the last 52 weeks. The beta is 2.30, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | +163.38% |
| 50-Day Moving Average | 79.16 |
| 200-Day Moving Average | 59.22 |
| Relative Strength Index (RSI) | 49.33 |
| Average Volume (20 Days) | 862,108 |
Short Selling Information
The latest short interest is 9.81 million, so 12.01% of the outstanding shares have been sold short.
| Short Interest | 9.81M |
| Short Previous Month | 9.36M |
| Short % of Shares Out | 12.01% |
| Short % of Float | 18.02% |
| Short Ratio (days to cover) | 13.07 |
Income Statement
In the last 12 months, KYMR had revenue of $39.21 million and -$311.35 million in losses. Loss per share was -$3.69.
| Revenue | 39.21M |
| Gross Profit | -277.36M |
| Operating Income | -345.54M |
| Pretax Income | -311.35M |
| Net Income | -311.35M |
| EBITDA | -338.83M |
| EBIT | -345.54M |
| Loss Per Share | -$3.69 |
Full Income StatementBalance Sheet
The company has $848.28 million in cash and $82.25 million in debt, with a net cash position of $1.54 billion or $18.83 per share.
| Cash & Cash Equivalents | 848.28M |
| Total Debt | 82.25M |
| Net Cash | 1.54B |
| Net Cash Per Share | $18.83 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 19.42 |
| Working Capital | 788.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$232.89 million and capital expenditures -$1.45 million, giving a free cash flow of -$234.34 million.
| Operating Cash Flow | -232.89M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | -234.34M |
| FCF Per Share | -$2.87 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -881.24% |
| Pretax Margin | -794.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.59% |
| Shareholder Yield | -12.59% |
| Earnings Yield | -4.57% |
| FCF Yield | -3.44% |
Analyst Forecast
The average price target for KYMR is $108.04, which is 29.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $108.04 |
| Price Target Difference | 29.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 25.65% |
| EPS Growth Forecast (5Y) | 4.45% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 10.92 and a Piotroski F-Score of 2.
| Altman Z-Score | 10.92 |
| Piotroski F-Score | 2 |
